Building the companies that will define the future
I’m Dr. Valeria Kogan — a scientist turned founder, turning breakthrough innovation into bold companies that transform industries and shape what comes next
I started my career in science, completing a PhD in bioinformatics before moving into entrepreneurship. My first company, Smartomica, brought AI into precision medicine, helping physicians personalize cancer treatment and showing me what it takes to move breakthrough science beyond the lab and into the real world.
Later, I founded Fermata, an AgTech company using AI and computer vision to tackle one of the most fundamental challenges of our time: food security. By helping growers detect pests and diseases earlier, reduce crop loss, and improve sustainability, Fermata has grown into an international company and has been recognized globally as a leader in both agriculture and AI.
Along the way, I was recognized by Forbes 30 Under 30, named a World Economic Forum Technology Pioneer, and received the Shimon Peres Heritage Initiative award for social impact.
Through this journey, I have seen how bold innovation becomes transformative only when it is matched by vision, execution, and the ability to scale in the real world. My work sits at the intersection of science, business, and long-term systems change — building companies, ideas, and platforms that can transform industries and shape what comes next.
Awards/Recognition
Who I Work With
Start-ups
DeepTech & high-growth founders
Many founders know how to explain their product. Far fewer know how to position their company as something investors, customers, and partners see as inevitable.
I help founders move beyond the product pitch and build a company narrative grounded in real market logic, operational credibility, and long-term ambition.
Ag & Food Companies
Ag, food, and industrial innovators
Large organizations often know where they want to innovate, but struggle to get close enough to the customer and operational reality early on. As a result, promising ideas can stay too abstract for too long, or move forward on the basis of internal assumptions rather than real market pull.
I work with leadership teams and innovation groups at this critical stage: helping them sharpen the opportunity, pressure-test the assumptions, and define a product direction that is grounded in actual customer needs and field reality.
Venture Capital
VCs and funds in AgTech, biotech, climate, and DeepTech
In science- and technology-heavy sectors, a strong deck, strong science, or even early pilot traction can hide major execution risk. Some companies are technically impressive but commercially fragile. Others are directionally right, but far less scalable than they appear.
I help investors look beyond the pitch and assess how likely a company is to work in the real world.